Astrazeneca ADR Stock
€73.50
Your prediction
Astrazeneca ADR Stock
Pros and Cons of Astrazeneca ADR in the next few years
Pros
Cons
Performance of Astrazeneca ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Astrazeneca ADR | 0.680% | 0.000% | 7.353% | 3.546% | 14.063% | 28.521% | 55.983% |
GSK plc ADR | -0.530% | 0.535% | 8.046% | 5.618% | 14.634% | 20.513% | -5.409% |
Bayer AG ADR | 2.240% | -6.294% | -4.286% | 4.688% | 35.081% | -43.697% | -44.167% |
Novo Nordisk A/S ADR | 1.120% | -3.254% | 4.808% | -55.409% | -41.328% | -54.372% | -21.520% |
News

3 Magnificent Stocks Under $100 to Buy Right Now
Share price has nothing to do with whether a stock is fairly valued. However, it is nonetheless an important consideration for investors on tight budgets.
With that in mind, three Fool.com

Why AstraZeneca Stock Was Topping the Market on Tuesday
AstraZeneca (NASDAQ: AZN) reported an estimates-busting quarter Tuesday morning, and a satisfied market rewarded the company for it. At market close the sturdy pharmaceutical stock had risen by

Why AstraZeneca Stock Got Thumped on Thursday
AstraZeneca (NASDAQ: AZN) might soon be on the hook for an eventual 11-figure payout, and investors weren't all that comfortable with this. A Bloomberg article published Thursday morning said that